As of 2025-10-13, the Relative Valuation of Eli Lilly and Co (LLY) is 322.41 USD. This relative valuation is based on P/E multiples. With the latest stock price at 833.49 USD, the upside of Eli Lilly and Co based on Relative Valuation is -61.3%.
The range of the Relative Valuation is 238.45 - 566.31 USD.
| Range | Selected | |
| Trailing P/E multiples | 23.5x - 38.8x | 27.0x |
| Forward P/E multiples | 17.9x - 20.2x | 19.0x |
| Fair Price | 238.45 - 566.31 | 322.41 |
| Upside | -71.4% - -32.1% | -61.3% |
| Date | P/E |
| 2025-10-10 | 57.16 |
| 2025-10-09 | 58.66 |
| 2025-10-08 | 58.00 |
| 2025-10-07 | 57.86 |
| 2025-10-06 | 57.96 |
| 2025-10-03 | 57.60 |
| 2025-10-02 | 56.23 |
| 2025-10-01 | 56.61 |
| 2025-09-30 | 52.33 |
| 2025-09-29 | 49.83 |
| 2025-09-26 | 49.69 |
| 2025-09-25 | 49.01 |
| 2025-09-24 | 50.88 |
| 2025-09-23 | 51.23 |
| 2025-09-22 | 51.78 |
| 2025-09-19 | 51.57 |
| 2025-09-18 | 52.33 |
| 2025-09-17 | 52.13 |
| 2025-09-16 | 52.45 |
| 2025-09-15 | 51.31 |
| 2025-09-12 | 51.81 |
| 2025-09-11 | 51.87 |
| 2025-09-10 | 51.76 |
| 2025-09-09 | 51.48 |
| 2025-09-08 | 50.66 |
| 2025-09-05 | 49.88 |
| 2025-09-04 | 50.95 |
| 2025-09-03 | 50.60 |
| 2025-09-02 | 50.42 |
| 2025-08-29 | 50.24 |
| 2025-08-28 | 50.20 |
| 2025-08-27 | 50.35 |
| 2025-08-26 | 50.48 |
| 2025-08-25 | 47.69 |
| 2025-08-22 | 48.81 |
| 2025-08-21 | 48.68 |
| 2025-08-20 | 48.38 |
| 2025-08-19 | 48.23 |
| 2025-08-18 | 47.88 |
| 2025-08-15 | 48.09 |
| 2025-08-14 | 46.94 |
| 2025-08-13 | 45.30 |
| 2025-08-12 | 43.86 |
| 2025-08-11 | 43.57 |
| 2025-08-08 | 42.91 |
| 2025-08-07 | 43.95 |
| 2025-08-06 | 51.19 |
| 2025-08-05 | 52.53 |
| 2025-08-04 | 52.74 |
| 2025-08-01 | 52.28 |